Morgan Stanley and EPAM Systems Contribute to Finos Open Source Movement

Morgan's Morphir offering is a transparency and efficiency tool for both users and developers; EPAM's GLUE is aimed at the buy side.

web
Vidar Nordli-Mathisen

In the two years since its founding, the Fintech Open Source Foundation (Finos) has gone from a community dominated by small, cutting-edge fintechs to a playground for major sell-side institutions and their own big ideas.

Finos is a nonprofit whose mission is to promote the adoption of open-source software and open standards in finance. Through the organization, companies and individual developers (through GitHub, a Finos platinum member) contribute the source code for tools they’ve built to

Only users who have a paid subscription or are part of a corporate subscription are able to print or copy content.

To access these options, along with all other subscription benefits, please contact info@waterstechnology.com or view our subscription options here: http://subscriptions.waterstechnology.com/subscribe

You are currently unable to copy this content. Please contact info@waterstechnology.com to find out more.

Sorry, our subscription options are not loading right now

Please try again later. Get in touch with our customer services team if this issue persists.

New to Waterstechnology? View our subscription options

Register for free

Access two articles, our IMD and Waters Wraps, plus a member newsletter. Find out more.

All fields are mandatory unless otherwise highlighted.

This address will be used to create your account

Removal of Chevron spells t-r-o-u-b-l-e for the C-A-T

Citadel Securities and the American Securities Association are suing the SEC to limit the Consolidated Audit Trail, and their case may be aided by the removal of a key piece of the agency’s legislative power earlier this year.

Most read articles loading...

You need to sign in to use this feature. If you don’t have a WatersTechnology account, please register for a trial.

Sign in
You are currently on corporate access.

To use this feature you will need an individual account. If you have one already please sign in.

Sign in.

Alternatively you can request an individual account here